Related Experiment Video
Updated: Oct 9, 2025

Functional Assessment of Kinesin-7 CENP-E in Spermatocytes Using In Vivo Inhibition, Immunofluorescence and Flow Cytometry
Published on: December 28, 2021
[Epigenetic regulation for spermatogenic dysfunction-related infertility in C57BL/6J male mice: An experimental
Peng DU1, Xiao-Li Zhang2, Xiao-Yong Zhao2
1Department of Reproductive Health and Infertility, Guangdong Maternal and Child Health Hospital, Guangzhou, Guangdong 510010, China.
Objective:
To investigate the effect of epigenetic regulation on spermatogenic dysfunction-related infertility (SDI) in C57BL/6J male mice.
Methods:
Sixty C57BL/6J male mice were randomly divided into a normal control and an SDI model group and the SDI model was established using the epididymis-targeting polypeptide CSA combined with indocyanine green-loaded free nanoparticles (ICG-NPS), busufan and dimethyl sulfoxide (DSMO). After intervention with 5-AZA-DC, the epididymides were collected from the mice for measurement of the rates of sperm DNA fragmentation (SDF), sperm acrosome integrity (SAI) and spontaneous acrosome reaction (SAR), amplification of the ERp29 gene by FISH, determination of the mRNA and protein expressions of DNMT1, ERp29, PTEN and TSC2 by quantitative real-time PCR and Western blot, and analysis of the ERp29, PTEN and TSC2 genes by methylated DNA immunoprecipitation sequencing (MeDIP-seq).
Results:
After 5-AZA-DC intervention, statistically significant differences were observed between the normal control and the SDI model groups in the rates of SDF ([15.67 ± 1.33]% vs [30.15 ± 2.87]%, P < 0.05) and SAI ([65.33 ± 7.14]% vs [47.16 ± 3.45]%, P < 0.05), but not SAR ([11.52 ± 2.31]% vs [11.48 ± 2.27]%, P > 0.05). FISH confirmed evident amplification of the ERp29 gene in the SDI model but not in the normal control group. Compared with the baseline, the SDI model mice showed significant decreases after intervention in the mRNA and protein expressions of DNMT1 ([9.33 ± 1.15] vs [7.01 ± 1.14], P < 0.05; [15.66 ± 1.45] vs [12.33 ± 1.27], P < 0.05), but increases in those of ERp29 ([3.04 ± 1.13] vs [6.54 ± 1.18], P < 0.05; [4.37 ± 1.02] vs [6.95 ± 1.03], P < 0.05), PTEN ([3.25 ± 1.01] vs [5.85 ± 1.04], P < 0.05; [3.54 ± 1.01] vs [5.17 ± 1.02], P < 0.05) and TSC2 ([4.27 ± 1.16] vs [6.98 ± 1.13], P < 0.05; [3.83 ± 1.12] vs [6.98 ± 1.13], P < 0.05). No statistically significant differences, however, were found in the above parameters in the normal control group before and after intervention (P > 0.05). MeDIP-seq manifested 18 significantly differential genes were highly expressed and another 25 lowly expressed in the epididymal tissue of the model mice, all the former 18 down-regulated and all the latter 25 up-regulated after intervention, particularly ERp29, PTEN and TSC2. But there were no statistically significant differences in the expressions of the above genes in the control group (P > 0.05). MeDIP-seq also showed significant differences in the regional methylation levels of the Erp29, PTEN and TSC2 promoters in the epididymal tissue of the model mice (P < 0.05), but not in that of the normal controls after intervention (P > 0.05).
Conclusions:
A stable and efficient animal model provided valuable experimental evidence for the diagnosis and treatment of spermatogenic dysfunction-related infertility. ERp29 is an important gene involved in infertility and can be used as a potential target for epigenetic regulation in the treatment of infertility.
Insights
Epigenetic regulation impacts male infertility. The study found ERp29 gene is crucial in spermatogenic dysfunction and may be a therapeutic target for infertility treatment.
Area of Science:
- Reproductive Biology
- Epigenetics
- Genetics
Background:
- Spermatogenic dysfunction-related infertility (SDI) affects male reproductive health.
- Epigenetic mechanisms play a role in regulating gene expression during spermatogenesis.
- Understanding these mechanisms is crucial for developing effective treatments for male infertility.
Purpose of the Study:
- To investigate the role of epigenetic regulation in spermatogenic dysfunction-related infertility (SDI) in a mouse model.
- To identify potential molecular targets for therapeutic intervention in SDI.
Main Methods:
- Establishment of an SDI mouse model using specific chemical agents and nanoparticles.
- Intervention with 5-AZA-DC (an epigenetic modifier).
- Assessment of sperm parameters, gene expression (ERp29, DNMT1, PTEN, TSC2), and DNA methylation patterns using FISH, qPCR, Western blot, and MeDIP-seq.
Main Results:
- The SDI model showed significantly increased sperm DNA fragmentation and decreased sperm acrosome integrity compared to controls.
- ERp29 gene amplification was observed in the SDI model.
- Intervention with 5-AZA-DC modulated the expression of DNMT1, ERp29, PTEN, and TSC2, and altered DNA methylation patterns in the SDI model.
- ERp29, PTEN, and TSC2 were identified as key genes affected by epigenetic changes in SDI.
Conclusions:
- A stable and efficient SDI mouse model was successfully established.
- Epigenetic alterations, particularly involving the ERp29 gene, are implicated in spermatogenic dysfunction.
- ERp29 presents a potential therapeutic target for epigenetic regulation in treating infertility.
Related Concept Videos
Spermatogenesis
Infertility in Males

